July 29, 2020 06:08 PM IST Mindspace REIT public issue consists of a fresh issue of Rs 1,000 crore and an offer for sale of Rs 3,500 crore.
July 28, 2020 07:23 PM IST The issue will close on July 29 and the bids can be made for minimum 200 units and in multiples of 200 units thereafter.
July 27, 2020 07:37 PM IST From an investor standpoint, the REIT product is a must-have in any portfolio, said Sharad Mittal, CEO at Motilal Oswal Real Estate Fund.
July 27, 2020 02:39 PM IST REIT is an investment tool that owns and operates rent-yielding real estate assets. It allows individual investors to invest using this platform and earn income.
July 26, 2020 03:56 PM IST IIFL Securities has recommended the issue for investors seeking returns similar to debt asset class.
July 25, 2020 03:02 PM IST Mindspace has so far raised Rs 2,643.74 crore from strategic and anchor investors, which is 58.74 percent of the total issue size of Rs 4,500 crore.
July 17, 2020 03:09 PM IST Ajcon Research Rossari Biotech Started in CY03 as “Rossari Lab tech”, a partnership firm, Rossari was converted to Company in CY09 by Mr. Edward Menezes and Mr. Sunil Chari.
July 17, 2020 03:06 PM IST The maximum bids received at lower end of price band of Rs 12-13 per share. In fact, the anchor book, through which the lender had received Rs 4,098 crore, was also subscribed at Rs 12 per share.
July 16, 2020 01:03 PM IST The FPO is largely aimed at ensuring adequate capital buffer to support growth plans, alongside absorbing further stress points from high NPA levels.
July 15, 2020 11:58 AM IST The public issue consists of a fresh issue of Rs 50 crore and an offer for sale of 1.05 crore equity shares by its promoters Edward Menezes and Sunil Chari.
July 14, 2020 08:07 PM IST Bay Tree India Holdings I, owned by Tilden Park, was the largest anchor investor, investing Rs 2,250 crore in Yes Bank for an allocation of 1,87,50,00,000 shares
July 14, 2020 02:40 PM IST In past 3 years (FY17-FY20), company has delivered stupendous growth on revenue, EBITDA and net profit level, which grew at a CAGR of 42 percent, 57 percent and 60 percent respectively.
July 14, 2020 11:58 AM IST After fixing of the price band, which is much lower than the market price, the stock has lost 22 percent.
July 13, 2020 06:07 PM IST Emkay Global Financial Rossari Biotech is planning to raise ~Rs4.95bn through a mix of fresh issue (Rs500mn, 1.17mn shares) combined with Offer for Sale (OFS) route (~Rs4.45bn, 10.5mn shares), to the public.
July 13, 2020 05:47 PM IST Motilal Oswal Hence, investors can Subscribe the IPO from a long term perspective.
July 13, 2020 05:31 PM IST Ventura Securities Rossari Biotech (Rossari) is one of the leading specialty chemicals manufacturing company in India, catering to various customer needs across FMCG, apparel, and poultry and animal feed industries.
July 13, 2020 05:16 PM IST Mehta Equities has come out with its report on Rossari Biotech. The research firm has recommended to "Subscribe'' the IPO in its research report as on July 10, 2020
July 13, 2020 05:14 PM IST Arihant Capital has come out with its report on Rossari Biotech. The research firm has recommended to "Subscribe'' the IPO in its research report as on July 10, 2020
July 13, 2020 05:13 PM IST Hem Securities has come out with its report on Rossari Biotech. The research firm has recommended to "Subscribe'' the IPO in its research report as on July 10, 2020
July 13, 2020 05:11 PM IST Anand Rathi has come out with its report on Rossari Biotech. The research firm has recommended to "Subscribe'' the IPO in its research report as on July 10, 2020
July 13, 2020 04:55 PM IST Choice Equity Broking has come out with its report on Rossari Biotech. The research firm has recommended to "Subscribe'' the IPO in its research report as on July 10, 2020
July 13, 2020 02:27 PM IST The company already garnered Rs 149 crore through its anchor book on July 10 and has been subscribed 8 percent so far on July 13, day one of bidding
July 13, 2020 01:59 PM IST While the valuation may appear high, experts point to the company's strong financial performance, lean balance sheet and plans to double capacity over the next year, which, they say, will boost growth.
July 13, 2020 01:23 PM IST Geojit Rossari Biotech Limited (RB) is one of the leading manufacturer of specialty chemicals in India with a diversified product profile of 2,030 products.
July 13, 2020 01:15 PM IST Angel Broking At the upper end of the price band, Rossari demands PE multiple of 32.1x F.Y.20 fully diluted EPS.
